Saudi Arabia approves first CRISPR/Cas9 gene-edited therapy for treatment of sickle cell disease

US-based Vertex Pharmaceuticals Incorporated has announced that the Saudi Food and Drug Authority (SFDA) has g...

January 12, 2024 | Friday | News
SGD Pharma Unveils Ambitious 2024 Growth Strategy, Aiming for Market Leadership Through Strategic Investments

Underpinning this objective Rousseau outlines the investment achievements already notched up in 2023, to illustrate how ...

January 12, 2024 | Friday | News
Enterprise Singapore & A*STAR upholds Singapore's promising biomedical companies at JPM 2024 Conference

By Hithaishi Bhaskar The 42nd Annual Healthcare Conference was held on January 8-11, 2024 in San Francisco, CA. Global ...

January 12, 2024 | Friday | News
Rethinking pharmacovigilance efficiencies amidst APAC's diverse regulatory landscape and rising drug development costs

Globally, the pursuit for treatments with better patient outcomes and more effective care is a never-ending quest. As di...

January 11, 2024 | Thursday | Analysis
Novel CAR T-cell therapy regimen to augment oncology care for hard-to-treat cancers

Tony Li, Senior Director and Head of Medical Affairs, Intercontinental Region, Gilead and Kite Oncology Kite Pharma, a ...

January 11, 2024 | Thursday | Opinion
Biotech and Biopharma Industry Trends: What to Watch for in 2024

Emerging biotech and biopharma (EBP) companies continue to drive global medical innovation, with Asia Pacific playing a ...

January 10, 2024 | Wednesday | Opinion
Specialised Therapeutics, Ascendis Pharma to commercialise endocrinology therapies in Australia and SE Asia

Singapore-based biopharmaceutical company Specialised Therapeutics Asia (ST) has added three new endocrinology ther...

January 8, 2024 | Monday | News
Merck expands colorectal cancer portfolio through licensing agreement with Inspirna for $45 M

Merck, a leading science and technology company, has announced a licensing agreement with US-based firm Inspirna, Inc. f...

January 5, 2024 | Friday | News
Menarini Group and Insilico Medicine ink oncology deal worth $500 M

The Menarini Group, a leading international pharmaceutical and diagnostics company headquartered in Italy, and Stemline ...

January 5, 2024 | Friday | News
Japan introduces world's first machine learning model to screen Alzheimer's disease

Japan-based Oita University and pharmaceutical firm Eisai Co. have announced the development of the world's first machin...

January 2, 2024 | Tuesday | News
What's Propelling mRNA Therapies Today?

The commercialisation of the first mRNA vaccine for COVID-19 in 2021 was a turning point in the journey of this four dec...

December 31, 2023 | Sunday | Opinion
“Pharma companies in South Korea will need to invest in skill development”

How is the contract manufacturing/development sector evolving in Korea? How is West leveraging opportunities in this spa...

January 5, 2024 | Friday | Opinion
Tech Trends for Life Sciences to Watch in 2024

There are three key areas changing the face of life sciences globally – precision medicine, artificial intelligenc...

December 31, 2023 | Sunday | Opinion
Digitalisation Pharma Tech Trends to look for in 2024

Year after year, trends in life sciences evolve to meet the industry’s ever-changing needs. This includes growing ...

December 31, 2023 | Sunday | News
Transformative Life Sciences Trends for 2024

As we enter 2024, we predict the technology trends that will influence the life sciences industry in the upcoming year. ...

January 2, 2024 | Tuesday | Analysis
BioSpectrum Asia wraps up 2023 with '23 Most Popular Stories'

    ...

December 28, 2023 | Thursday | News
Japan-Germany collaboration for cancer research to design novel immunotherapies

BioMed X has announced a new joint research project with Ono Pharmaceutical, marking the start of the collaboration betw...

December 28, 2023 | Thursday | News
Biocon Biologics partners with Sandoz for distribution of Adalimumab biosimilar in Japan

Indian firm Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of B...

December 22, 2023 | Friday | News
AstraZeneca buys biotech startup Gracell for $1 B to further cell therapy ambition

British biophamaceutical firm AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc...

December 26, 2023 | Tuesday | News
Indian firm Intas Pharma inks new licensing agreement for treating autoimmune diseases in 150+ countries

Intas Pharmaceuticals, a leading multinational pharmaceutical company in India, has announced a strategic exclusive lice...

December 20, 2023 | Wednesday | News
"Novartis is collaborating with governments from Korea, Malaysia, Taiwan, and the UAE and Singapore to advance education around heart health"

What is the current burden of cardiovascular diseases in the Asia Pacific, Middle East and Africa (APMA) region? G...

December 18, 2023 | Monday | Opinion
Japan-based GHIT Fund invests $8.8 M in new drug development projects for malaria

The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced an investment of approximatel...

December 15, 2023 | Friday | News
LEQEMBI to launch in Japan for Alzheimer's disease on December 20

Swedish firm BioArctic AB's partner Eisai has announced that LEQEMBI (lecanemab) will be launched in Japan&nbs...

December 13, 2023 | Wednesday | News
French firm Depixus collaborates with Japan's Daiichi Sankyo to accelerate RNA-targeted drug discovery

Interactomics pioneer Depixus, based in Paris, has entered a collaboration with Daiichi Sankyo to use their novel MAGNA ...

December 12, 2023 | Tuesday | News
South African firm Aspen to acquire Sandoz's China business

South Africa based Aspen Pharmacare Holdings Limited, a global multinational specialty pharmaceutical company, has ...

December 11, 2023 | Monday | News